JANET FARHIE: Open Payments
NPI 1871680223 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 7 payments from 6 companies in 2025. Trend: 2023 $313 · 2024 $523 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $263 |
| E.R. Squibb & Sons, L.L.C. | 1 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 1 | $99 |
Products named: UZEDY, COBENFY, CAPLYTA, FANAPT, LYBALVI, REXULTI.
Industry payments across CA — which companies pay providers there.
